Brisbane Times
·general
·1 hour ago
Perth biotech Syngenis unleashes AI drug discovery push
Perth biotech Syngenis Laboratories launched an AI-powered drug discovery platform on Monday to accelerate molecular therapy identification. The system compresses traditional testing that takes months into hours by analysing billions of genetic combinations from databases like NCBI's 6.27 billion sequence records. The platform targets RNA and DNA-based medicines, with the company planning an ASX float.
Summary by Glance · Brisbane Times
Newer
Next
Loving doing this? 🎉
Take it further — get the full app and never miss a moment of what's happening in Australia.
Breaking news alerts
Instant lock-screen notifications the moment big stories break across Australia.
Australian news & events
Politics, sport, weather, local events — all in one swipeable feed, updated around the clock.
Stay ahead of the news cycle
30-second summaries so you're always informed, even on your busiest days.
Loading article…
This publisher's site can't be shown here due to their security settings.
Open full article →No source link available for this article.
✨
Ask AI